首页> 外文期刊>Respiration: International Review of Thoracic Diseases >Comparison of rigid and flexible transbronchial needle aspiration in the staging of bronchogenic carcinoma.
【24h】

Comparison of rigid and flexible transbronchial needle aspiration in the staging of bronchogenic carcinoma.

机译:硬性和柔性经支气管针抽吸术在支气管癌分期中的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

In staging bronchogenic carcinoma by transbronchial needle aspiration (TBNA), rigid histology needles are generally preferred to flexible cytology needles owing to the widespread opinion that rigid needles have higher diagnostic yield and less false-positive results. The objective of this study was to compare the efficacy and safety of the rigid and flexible TBNAs in staging bronchogenic carcinoma to establish whether a flexible cytology needle method can replace the rigid needle. A prospective study was conducted in 138 consecutive patients with extra- or endobronchial masses suggestive of bronchogenic carcinoma and amenable to surgical procedures. All 8 mm and larger paratracheal, carinal, hilar and/or main bronchial lymph nodes determined before bronchoscopy by computed tomography (CT) were sampled by successive 18-gauge rigid and 21-gauge flexible TBNAs in the same session. The anatomic landmarks were followed precisely during TBNAs, and a proper technique applied in sampling and specimen processing. Malignant lymph node involvement was specified in 97 (72%) cases of bronchogenic carcinoma by rigid, and in 89 (66%) by flexible TBNA. There were 4 (100%) benign cases (3 with tuberculosis and 1 with sarcoidosis) of 101 (73%) with positive rigid TBNAs (82 with histological and 19 with cytological specimens). TBNAs determined malignant lymph node involvement in a total of 104 (78%) patients. Of 30 TBNA-negative patients, 14 were proven to have false-negative TBNAs by mediastinoscopy/mediastinotomy/minithoracotomy, and 16 to have true-negative TBNAs by thoracotomy. Thoracotomy confirmed true positivity in 52 rigid and 49 flexible TBNAs, and false negativity in 4 rigid and 7 flexible TBNAs. Further staging was confirmed in these 7 cases. Four had proven false-negative results by both methods. The presence of small cell carcinoma (21) or N3 disease (27) presented a contraindication to thoracotomy in 48 TBNA-positive patients. Adequate-quality and malignant lymph node specimens were more frequently obtained by both techniques at advanced tumor and node stages. However, malignant lymph node invasion was significantly more frequent in rigid and flexible TBNA specimens only in the presence of advanced tumor status and abnormal endoscopic appearance. The sensitivities of rigid and flexible TBNAs were 74 and 70%, respectively (p > 0.05), but both had a specificity of 100%. Neither false-positive results nor serious complications other than hemorrhage of 30-100 ml (rigid: 5%, flexible: 2%) were encountered with either technique. These results indicate that in bronchogenic carcinoma, hilar and mediastinal lymph nodes can be staged by 21-gauge flexible TBNA (76%) as accurately as by 18-gauge rigid TBNA (79%) if a proper technique is applied and anatomic landmarks are followed precisely (p > 0.05).
机译:在通过经支气管针抽吸术(TBNA)分型支气管癌中,由于广泛的观点认为刚性针具有更高的诊断率和更少的假阳性结果,刚性组织学针通常优于柔性细胞学针。这项研究的目的是比较刚性和柔性TBNA在分期支气管癌中的疗效和安全性,以确定柔性细胞学针法是否可以代替刚性针。前瞻性研究在138例连续支气管内或支气管外肿块患者中进行,提示有支气管癌并适合手术。通过计算机断层扫描(CT)在支气管镜检查之前确定的所有8毫米及更大的气管旁,支气管,肺门和/或主支气管淋巴结均在同一疗程中通过连续的18号刚性和21号挠性TBNA采样。在TBNA期间精确地遵循解剖标志,并在采样和标本处理中应用了适当的技术。坚硬的支气管癌病例中有97例(72%)发生了恶性淋巴结受累,挠性TBNA有89例(66%)中有恶性淋巴结受累。有4例(100%)良性病例(3例为结核病,1例为结节病),其中刚性TBNA阳性为101例(73%)(组织学为82例,细胞学标本为19例)。 TBNA确定了104例(78%)患者的恶性淋巴结受累情况。在30例TBNA阴性患者中,有14例经纵隔镜/纵隔切开术/微型开胸术证实为假阴性TBNA,而16例经开胸术证实为阴性。开胸手术证实了52个刚性和49个挠性TBNA的真实阳性,4个刚性和7个挠性TBNA的阴性阴性。在这7例病例中证实了进一步的分期。两种方法均证明了假阴性结果。小细胞癌(21)或N3疾病(27)的存在是48例TBNA阳性患者开胸的禁忌症。在晚期肿瘤和淋巴结分期,两种技术均较常获得足够质量和恶性的淋巴结标本。但是,仅在存在晚期肿瘤状态和异常内窥镜外观的情况下,刚性和柔性TBNA标本中恶性淋巴结浸润的发生率才明显更高。刚性和柔性TBNA的敏感性分别为74%和70%(p> 0.05),但两者的特异性均为100%。两种技术均未见假阳性结果或严重并发症,但出血量为30至100 ml(刚性:5%,柔性:2%)。这些结果表明,如果采用适当的技术并遵循解剖学标志,则在21根柔性TBNA(76%)和18根刚性TBNA(79%)的分期中,在支气管癌中,肺门和纵隔淋巴结的分期准确度高。精确地(p> 0.05)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号